PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma
Lists
Only you see this
Abstract
Our cross-species analysis has identified PPP1R15A as a therapeutic target governing the anti-T-cell activities of fibrosis-associated M-MDSCs (monocytic myeloid-derived suppressor cells). The results from the preclinical models show that specific inhibition of PPP1R15A can break the immunosuppressive barrier to restrict hepatocellular carcinoma growth and enhance the efficacy of immune checkpoint blockade. PPP1R15A may also function as a prognostic and/or predictive biomarker in patients with hepatocellular carcinoma.
BibTeX
@inproceedings{liu2024ppp,
author = {Xiaoyu Liu and Man Liu and Haoran Wu and Wenshu Tang and Weiqin Yang and Thomas Ting-Hei Chan and Lingyun Zhang and Shufen Chen and Zhewen Xiong and Jianxin Liang and Willis Wai-Yiu Si-Tou and Ting Shu and Jingqing Li and Jian Cao and Chengpeng Zhong and Hanyong Sun and Tsz Tung Kwong and Howard H.W. Leung and John Wong and Paul Bo-San Lai and Ka‐Fai To and Tingxiu Xiang and Joseph J.�Y. Sung and Stephen L. Chan and Jingying Zhou and Alfred S.L. Cheng},
title = {{PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma}},
booktitle = {JHEP},
year = {2024},
doi = {10.1016/j.jhepr.2024.101087},
}Loading related content...